Cambridge Healthtech Institute Training Seminars offer real-life case studies, problems encountered and solutions applied, along with extensive coverage of the academic theory and background. Each training seminar offers a mix of formal lecture and interactive discussions and activities to maximize the learning experience. These training seminars are led by experienced instructors who will focus on content applicable to your current research and provide important guidance those new to their fields.

PEGS Boston 2020:

Introduction to Protein Engineering
Instructor:
David Bramhill, PhD, Founder, Bramhill Biological Consulting, LLC

Introduction to Structure-Based Drug Design and Development
Instructors:
Christopher Corbeil, PhD, Research Officer, Human Health Therapeutics, National Research Council Canada
Traian Sulea, PhD, Principal Research Officer, Human Health Therapeutics, National Research Council Canada

Introduction to Bispecifics: History, Engineering, and Applications
Instructor:
Rakesh Dixit, PhD, DABT; President & CEO, Bionavigen, LLC; CSO, SenecaTherapeutics

Introduction to Immunology for Drug Discovery Scientists
Instructor:
Masha Fridkis-Hareli, MSc, PhD, Founder and President, ATR, LLC

Antibody Deep Sequencing and Single-Cell Analysis
Instructors:
Brandon DeKosky, PhD, Assistant Professor, Department of Chemical Engineering, Department of Pharmaceutical Chemistry, Kansas Vaccine Institute, The University of Kansas
Matías Gutiérrez González, PhD, Postdoctoral Researcher, Pharmaceutical Chemistry, The University of Kansas

Introduction to Cancer Immunotherapy Discovery and Development
Instructor:
Dina Schneider, PhD, Associate Director, Translational Research, Lentigen Technology, Inc., a Miltenyi Biotec Company

Essentials in Bioassay Development and Validation
Instructor:
Thomas Little, PhD, President and CEO, Bioassay Sciences, Thomas A. Little Consulting

Introduction to Bioprocessing
Instructors:
Sheila G. Magil, PhD, Managing Director, Industry Specialized Services, BDO
Frank J. Riske, PhD, Managing Director, Industry Specialized Services, BDO

Introduction to Immunogenicity
Instructors:
Bonnie Rup, PhD, Independent Consultant
Sofie Pattijn, CTO, ImmunXperts

Genome Editing with CRISPR: Towards Novel Research, Translational, and Clinical Applications
Instructor:
Serguei Kozlov, PhD, MBA, PMP, Principal Scientist/PM, Team Leader PTO, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research (NCI)

Bioprocessing Summit Europe 2020:

Intro to Gene Therapy and Viral Vectors

Instructors:
Jerrod Denham, Principal, Dark Horse Consulting
Andrew Steinsapir, Consultant, Dark Horse Consulting

Drug Discovery Chemistry 2020:

GPCR Drug Discovery
Terry Kenakin, PhD, Professor, Department of Pharmacology, University of North Carolina School of Medicine

Introduction to Small Molecule Drug Metabolism and Development
John Erve, PhD, DABT, Jerve Scientific Consulting, Inc. 
Yurong Lai, PhD, Senior Director, Drug Metabolism, Gilead Sciences

Biotherapeutics Analytical Summit 2020:

Practical Strategies for Analytical Method Lifecycle Management for Biological Products
Nadine M. Ritter, PhD, President & Analytical Advisor, Global Biotech Experts LLC

Regulatory Requirements across the Product Development Lifecycle 
Christina Vessely, PhD, Senior Consultant, CMC Analytics & Formulation Development, Biologics Consulting Group, Inc.

World Pharma Week 2019:

Introductory Immunology for Cancer and Autoimmune Drug Discovery
Tim Bauler, PhD, Assistant Professor, Department of Biomedical Sciences, Western Michigan University Homer Stryker M.D. School of Medicine
Tom Sundberg, PhD, Group Leader, Cellular Pharmacology, Broad Institute of MIT and Harvard

Practical Introduction to PKPD Modeling in Drug Discovery and Development: Better, Faster, Cheaper
Arijit Chakravarty, CEO, Fractal Therapeutics
Ryan Nolan, PhD, Research Fellow, Takeda Pharmaceuticals 

Immuno-Oncology Summit 2019:

Introduction to Cancer Immunotherapy Discovery and Development - Detailed Agenda 
Dina Schneider, PhD, Associate Director, Translational Research, Lentigen Technology, a Miltenyi Biotec Company

 Introduction to Immunology for Drug Discovery Scientists - Detailed Agenda 
Masha Fridkis-Hareli, MSc, PhD, Founder and President, ATR, LLC
Tatiana Novobrantseva, PhD, Co-Founder, Head of Research and Development, Verseau Therapeutics

The Bioprocessing Summit 2019:

Introduction to Bioprocessing - Detailed Agenda

Sheila G. Magil, PhD, Principal Consultant, BioProcess Technology Consultants, Inc.

Frank J. Riske, PhD, Senior Consultant, BioProcess Technology Consultants, Inc.

Regulatory Requirements across the Product Development Lifecycle - Detailed Agenda

Christina Vessely, PhD, Senior Consultant, Analytical and Formulation Development, Biologics Consulting

Introduction Quality by Design (QbD) for Biopharmaceuticals - Detailed Agenda

Naveen Pathak, Director, Pharmaceutical Science, Takeda

Intro to Gene Therapy and Viral Vectors

Jerrod Denham, Principal, Dark Horse Consulting

Andrew Steinsapir, Consultant, Dark Horse Consulting

Introduction to Analytical Method Development and Validation for Biologics Products - Detailed Agenda

Jichao (Jay) Kang, PhD, RAC, Director, Analytical Development, Amicus Therapeutics

Bioprocess Strategies from Development to BLA - Detailed Agenda

Sheila G. Magil, PhD, Principal Consultant, BioProcess Technology Consultants, Inc.

Introduction to Biologics Formulation Development - Detailed Agenda:

Donald E. Kerkow, PhD, Director, Biopharmaceutical Development, KBI Biopharma, Inc.

Design of Experiments for Cell and Gene Therapies

Jerrod Denham, Principal, Dark Horse Consulting

Andrew Steinsapir, Consultant, Dark Horse Consulting

Protein Aggregation and Formulation Optimization - Detailed Agenda

Thomas Laue, PhD, Professor Emeritus, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire

Kevin Mattison, PhD, Principal Scientist, Malvern Pananalytical, Inc.

Next Generation Dx Summit 2019:

Introduction to Liquid Biopsy for Cancer - Detailed Agenda

Stuart S. Martin, PhD, Professor, Physiology, Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, University of Maryland School of Medicine

Introduction to Image Analysis and Deep Learning for Digital Pathology - Detailed Agenda

Kate Lillard Tunstall, PhD, CSO, Indica Labs, Inc.

Your NGS Lab: Relevant Issues from Test Development to Commercialization - Detailed Agenda

Jamie Platt, PhD, Managing Director, BRIDGenomics, LLC

Discovery on Target 2019:

Targeting GPCRs for Drug Discovery - Detailed Agenda
Terry Kenakin, PhD, Professor, Department of Pharmacology, University of North Carolina School of Medicine

An In-Depth Introduction to Drug Metabolism and Applications to Discovery and Development - Detailed Agenda 
John C.L. Erve, PhD, DABT, President, Jerve Scientific Consulting, Inc. 

Introduction to Small Molecule Drug Discovery and Development - Detailed Agenda
H. James Harwood Jr., PhD, Founder and CEO, Delphi BioMedical Consultants, LLC

Practical Phenotypic Screening - Detailed Agenda
Fabien Vincent, PhD, Associate Research Fellow, Discovery Sciences, Pfizer, Inc.

Contact: David Cunningham for Group Discounts at 781-972-5472

Each CHI Training Seminar offers 1.5 Days of instruction with start and stop times for each day shown above and on the Event-at-a-Glance published in the onsite Program & Event Guide. Training Seminars will include morning and afternoon refreshment breaks, as applicable, and lunch will be provided to all registered attendees on the full day of the class.

Each person registered specifically for the training seminar will be provided with a hard copy handbook for the seminar in which they are registered. A limited number of additional handbooks will be available for other delegates who wish to attend the seminar, but after these have been distributed no additional books will be available.

Though CHI encourages track hopping between conference programs, we ask that Training Seminars not be disturbed once they have begun. In the interest of maintaining the highest quality learning environment for Training Seminar attendees, and because Seminars are conducted differently than conference programming, we ask that attendees commit to attending the entire program, and NOT engaging in track hopping, as to not disturb the hands-on style instruction being offered to the other participants.